The prevalence rate of prescriptions for benzodiazepines and benzodiazepine-related drugs (BZD) — medications used to treat anxiety, insomnia, epilepsy and other neuropsychiatric conditions — increased by 22 percent between 2006 and 2013 among individuals aged 0-24 years in Sweden, according to a new study.